A case of Aripiprazole and extra-pyramidal side effects

Journal of Psychopharmacology

Volumn 20, Issue 4, 2006, Pages 592-593

  Salmoiraghi, Alberto ^a,c   Odiyoor, Mahesh ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b WARRINGTON AND HALTON HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Aripiprazole; Atypical antipsychotics extra pyramidal side effects; Parkinsonism; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; NEUROLEPTIC AGENT; OLANZAPINE; PROCYCLIDINE;

ADULT; AKATHISIA; ANAMNESIS; ANHEDONIA; ANTISOCIAL BEHAVIOR; ARTICLE; AUDITORY HALLUCINATION; BRAIN ATROPHY; BRAIN SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; FAMILY HISTORY; FEMALE; GAIT DISORDER; HOSPITAL ADMISSION; HUMAN; HYPERSALIVATION; MUSCLE STIFFNESS; NEGATIVE SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; SKELETAL MUSCLE; THOUGHT DISORDER; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; FEMALE; HUMANS; MIDDLE AGED; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA;

EID: 33745019145     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881106060194     Document Type: Article

References (9)

1. Cohen S T, Rulf D, Pies R (2005) Extrapyramidal side effects associated with Aripiprazole coprescription in two patients. Journal of Clinical Psychiatry 66: 135-136
2. Davies M A, Sheffler D J, Roth B L (2004) Aripiprazole: a novel antipsychotic drug with a uniquely robust pharmacology. CNS Drug Review 10: 317-336
3. DeLeon A, Patel N C, Crimson M L (2004) Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability. Clinical Therapeutics: The International Peer-Reviewed Journal of Drug Therapy 26: 649-666
4. Goodnick P J, Jerry J M (2002) Aripiprazole: profile on efficacy and safety. Expert Opinion on Pharmacotherapy 3: 1773-1781
5. Hirose T, Uwahodo Y, Yamada S, Miwa T, Kikuchi T, Kitagawa H, Burris K D, Altar C A, Nabeshima T (2004) Mechanism of action of Aripiprazole predicts clinical efficacy and a favourable side-effects profile. Journal of Psychopharmacology 18: 375-383
6. Li Z, Ichikawa J, Dai J, Meltzer H Y (2004) Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. European Journal of Pharmacology 493: 75-83
7. Lindsey R, Kaplan D, Koliatsos V, Walters J K, Sandson N B (2003) Aripiprazole and extrapyramidal symptoms. Journal of the American Academy of Child & Adolescent Psychiatry 42: 1268-1269
8. Schonberger R B, Douglas L, Baum C R (2004) Severe extrapyramidal symptoms in a 3 year-old boy after accidental ingestion of the new antipsychotic drug Aripiprazole. Pediatrics 114: 1743
9. World Health Organisation (1992) The ICD-10 classification of mental and behavioural disorders: clinical description and diagnostic guidelines. World Health Organization: Geneva